{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:52:45Z","timestamp":1790985165544,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Intact Vascular Inc"},{"name":"Intact Vascular Inc"},{"name":"480 Biomedical"},{"name":"Bard Peripheral Vascular"},{"name":"Veryan"},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010479","name":"Cook Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010479","id-type":"DOI","asserted-by":"publisher"}]},{"name":"W. L. Gore & Associates"},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008978","name":"Philips","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008978","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006432","name":"Terumo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006432","id-type":"DOI","asserted-by":"publisher"}]},{"name":"TriReme"},{"name":"Shockwave"},{"name":"Med Alliance"},{"name":"Intact Vascular"},{"name":"Intact Vascular Inc"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jvs.2020.01.078","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T11:29:06Z","timestamp":1589282946000},"page":"1636-1647.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Optimized drug-coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the Tack Endovascular System: TOBA III 12-month results"],"prefix":"10.1016","volume":"72","author":[{"given":"Marianne","family":"Brodmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wissgott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Brechtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Nikol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lichtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Blessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2020.01.078_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468","article-title":"Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial","volume":"3","author":"Laird","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.01.078_bib2","first-page":"CD011319","article-title":"Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs","volume":"8","author":"Kayssi","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2020.01.078_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/1526602819855396","article-title":"Dissections after infrainguinal percutaneous transluminal angioplasty: a systematic review and current state of clinical Evidence","volume":"26","author":"Armstrong","year":"2019","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.01.078_bib4","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/01.CIR.86.6.1845","article-title":"How does angioplasty work? Serial analysis of human iliac arteries using intravascular ultrasound","volume":"86","author":"Losordo","year":"1992","journal-title":"Circulation"},{"issue":"Pt 2","key":"10.1016\/j.jvs.2020.01.078_bib5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1148\/radiology.170.3.2521745","article-title":"Noncoronary angioplasty","volume":"170","author":"Becker","year":"1989","journal-title":"Radiology"},{"key":"10.1016\/j.jvs.2020.01.078_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jcin.2014.07.032","article-title":"Early experimental and clinical experience with a focal implant for lower extremity post-angioplasty dissection","volume":"8","author":"Schneider","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.01.078_bib7","series-title":"Coronary artery angiographic changes after PTCA. Manual of operations. NHLBI PTCA Registry","first-page":"6","year":"1985"},{"key":"10.1016\/j.jvs.2020.01.078_bib8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jvs.2014.04.061","article-title":"Disease-specific guidelines for reporting adverse events for peripheral vascular medical devices","volume":"60","author":"Ouriel","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.01.078_bib9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2014.12.036","article-title":"Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)","volume":"65","author":"Patel","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2020.01.078_bib10","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.01.078_bib11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jcin.2011.11.010","article-title":"Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry","volume":"5","author":"Micari","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.01.078_bib12","series-title":"Premarket approval application: P140010. Summary of safety and effectiveness data (SSED) IN.PACT Admiral paclitaxel-eluting percutaneous transluminal angioplasty balloon catheter","year":"2014"},{"key":"10.1016\/j.jvs.2020.01.078_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2014a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.jvs.2020.01.078_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jvs.2008.12.073","article-title":"The walking impairment questionnaire: an effective tool to assess the effect of treatment in patients with intermittent claudication","volume":"50","author":"Nicolai","year":"2009","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.01.078_bib15","doi-asserted-by":"crossref","first-page":"e000937","DOI":"10.1161\/CIRCINTERVENTIONS.113.000937","article-title":"Wire-interwoven nitinol stent outcome in the superficial femoral and proximal popliteal arteries: twelve-month results of the SUPERB trial","volume":"8","author":"Garcia","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.01.078_bib16","article-title":"Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results","author":"Dumantepe","year":"2015","journal-title":"Vascular"},{"key":"10.1016\/j.jvs.2020.01.078_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1583\/08-2676.1","article-title":"Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study","volume":"16","author":"Bosiers","year":"2009","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.01.078_bib18","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jvs.2013.01.050","article-title":"Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease","volume":"58","author":"Geraghty","year":"2013","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.01.078_bib19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1583\/13-4430R.1","article-title":"SUMMIT registry: one-year outcomes after implantation of the EPIC self-expanding nitinol stent in the femoropopliteal segment","volume":"20","author":"Werner","year":"2013","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.01.078_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/1526602817698634","article-title":"Angiographic dissection patterns and patency outcomes after balloon angioplasty for superficial femoral artery disease","volume":"24","author":"Fujihara","year":"2017","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.01.078_bib21","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10439-018-1990-1","article-title":"Nitinol stents in the femoropopliteal artery: a mechanical perspective on material, design, and performance","volume":"46","author":"Maleckis","year":"2018","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.jvs.2020.01.078_bib22","first-page":"387","article-title":"Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence","volume":"11","author":"Bishu","year":"2015","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jvs.2020.01.078_bib23","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2018.11.039","article-title":"Drug-eluting stent versus drug-coated balloon revascularization in patients with femoropopliteal arterial disease","volume":"73","author":"Bausback","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2020.01.078_bib24","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1583\/JEVT-12-3815MR.1","article-title":"Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the CALCIUM 360 randomized pilot trial","volume":"19","author":"Shammas","year":"2012","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.01.078_bib25","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a\u00a0drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2020.01.078_bib26","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.jcin.2017.06.018","article-title":"Drug-coated balloon treatment for femoropopliteal artery disease: the IN.PACT Global Study de novo in-stent restenosis imaging cohort","volume":"10","author":"Brodmann","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.01.078_bib27","doi-asserted-by":"crossref","first-page":"e005654","DOI":"10.1161\/CIRCINTERVENTIONS.117.005654","article-title":"Drug-coated balloon treatment for femoropopliteal artery disease","volume":"11","author":"Scheinert","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.01.078_bib28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1583\/13-4548R.1","article-title":"Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial","volume":"21","author":"Laird","year":"2014","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.01.078_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jvs.2016.02.043","article-title":"Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplasty","volume":"64","author":"Bosiers","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.01.078_bib30","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(11)61317-2","article-title":"US physicians urge end to unnecessary stent operations","volume":"378","author":"Devi","year":"2011","journal-title":"Lancet"}],"updated-by":[{"DOI":"10.1016\/j.jvs.2023.11.060","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000}}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074152142030330X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074152142030330X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T09:12:42Z","timestamp":1716023562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074152142030330X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S074152142030330X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2020.01.078","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jvs.2023.11.060","asserted-by":"object"}]},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimized drug-coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the Tack Endovascular System: TOBA III 12-month results","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2020.01.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}